R&D Blueprint

Zika R&D

After expert consulations, WHO has prioritized as the most viable R&D options to help fight the spread of Zika virus in the immediate future:

  • Multiplex tests for ‘flaviviruses’ (viruses related to Zika, such as dengue, chikungunya), in addition to more traditional tests;
  • Protective vaccines to prevent congenital Zika syndrome; and
  • Innovative vector control tools that reduce the mosquito population.

Target product profiles (TPPs)

Pipeline

More about Zika R&D

R&D key actions by diseases